nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—SHBG—osteoporosis	0.126	0.597	CbGaD
Medroxyprogesterone Acetate—breast cancer—Estradiol—osteoporosis	0.113	0.363	CpDpCtD
Medroxyprogesterone Acetate—breast cancer—Conjugated Estrogens—osteoporosis	0.113	0.363	CpDpCtD
Medroxyprogesterone Acetate—breast cancer—Ethinyl Estradiol—osteoporosis	0.0858	0.275	CpDpCtD
Medroxyprogesterone Acetate—ESR1—osteoporosis	0.0853	0.403	CbGaD
Medroxyprogesterone Acetate—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.048	0.523	CrCrCtD
Medroxyprogesterone Acetate—Testosterone—Estradiol—osteoporosis	0.0438	0.477	CrCrCtD
Medroxyprogesterone Acetate—SHBG—Estropipate—osteoporosis	0.0411	0.155	CbGbCtD
Medroxyprogesterone Acetate—ESR1—Estropipate—osteoporosis	0.0297	0.112	CbGbCtD
Medroxyprogesterone Acetate—AR—Ergocalciferol—osteoporosis	0.0275	0.104	CbGbCtD
Medroxyprogesterone Acetate—SHBG—Ethinyl Estradiol—osteoporosis	0.0265	0.0998	CbGbCtD
Medroxyprogesterone Acetate—ESR1—Raloxifene—osteoporosis	0.0198	0.0747	CbGbCtD
Medroxyprogesterone Acetate—ESR1—Ethinyl Estradiol—osteoporosis	0.0192	0.0722	CbGbCtD
Medroxyprogesterone Acetate—SHBG—Estradiol—osteoporosis	0.0171	0.0643	CbGbCtD
Medroxyprogesterone Acetate—AR—Estradiol—osteoporosis	0.0143	0.0538	CbGbCtD
Medroxyprogesterone Acetate—ESR1—Conjugated Estrogens—osteoporosis	0.0141	0.053	CbGbCtD
Medroxyprogesterone Acetate—ESR1—Estradiol—osteoporosis	0.0123	0.0465	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Estropipate—osteoporosis	0.00525	0.0198	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Raloxifene—osteoporosis	0.00502	0.0189	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Ethinyl Estradiol—osteoporosis	0.00485	0.0183	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Cholecalciferol—osteoporosis	0.00388	0.0146	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Estradiol—osteoporosis	0.00313	0.0118	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Calcitriol—osteoporosis	0.00305	0.0115	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Estropipate—osteoporosis	0.00305	0.0115	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Cholecalciferol—osteoporosis	0.0027	0.0102	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Ergocalciferol—osteoporosis	0.00244	0.00919	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Estradiol—osteoporosis	0.00218	0.00821	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Raloxifene—osteoporosis	0.00204	0.00767	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00197	0.00741	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Cholecalciferol—osteoporosis	0.00157	0.00593	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Conjugated Estrogens—osteoporosis	0.00144	0.00544	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Estradiol—osteoporosis	0.00127	0.00478	CbGbCtD
Medroxyprogesterone Acetate—Cyproterone acetate—CYP19A1—osteoporosis	0.000336	0.229	CrCbGaD
Medroxyprogesterone Acetate—Ethynodiol—ESR1—osteoporosis	0.000202	0.138	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—SHBG—osteoporosis	0.000149	0.101	CrCbGaD
Medroxyprogesterone Acetate—Spironolactone—SHBG—osteoporosis	0.000136	0.0928	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—SHBG—osteoporosis	0.00012	0.0819	CrCbGaD
Medroxyprogesterone Acetate—Fluoxymesterone—ESR1—osteoporosis	0.0001	0.0685	CrCbGaD
Medroxyprogesterone Acetate—Hydrocortisone—SHBG—osteoporosis	9.04e-05	0.0617	CrCbGaD
Medroxyprogesterone Acetate—Methyltestosterone—CYP19A1—osteoporosis	8.81e-05	0.0601	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—SHBG—osteoporosis	7.36e-05	0.0502	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—SHBG—osteoporosis	6.96e-05	0.0475	CrCbGaD
Medroxyprogesterone Acetate—Testosterone—CYP19A1—osteoporosis	5.11e-05	0.0349	CrCbGaD
Medroxyprogesterone Acetate—Progesterone—ESR1—osteoporosis	4.97e-05	0.0339	CrCbGaD
Medroxyprogesterone Acetate—Hypersensitivity—Ibandronate—osteoporosis	2.29e-05	0.000248	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Risedronate—osteoporosis	2.28e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Estradiol—osteoporosis	2.28e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Pamidronate—osteoporosis	2.27e-05	0.000247	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Conjugated Estrogens—osteoporosis	2.27e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Zoledronate—osteoporosis	2.26e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	2.26e-05	0.000246	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Ethinyl Estradiol—osteoporosis	2.26e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Alendronate—osteoporosis	2.25e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Risedronate—osteoporosis	2.25e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Estradiol—osteoporosis	2.25e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Estradiol—osteoporosis	2.24e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Ethinyl Estradiol—osteoporosis	2.24e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Zoledronate—osteoporosis	2.24e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Calcitriol—osteoporosis	2.24e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Estradiol—osteoporosis	2.23e-05	0.000243	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Conjugated Estrogens—osteoporosis	2.23e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Conjugated Estrogens—osteoporosis	2.23e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Conjugated Estrogens—osteoporosis	2.23e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Ibandronate—osteoporosis	2.23e-05	0.000242	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Conjugated Estrogens—osteoporosis	2.22e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Etidronic acid—osteoporosis	2.22e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Zoledronate—osteoporosis	2.22e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Zoledronate—osteoporosis	2.22e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	2.21e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Pamidronate—osteoporosis	2.21e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Estropipate—osteoporosis	2.21e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Risedronate—osteoporosis	2.21e-05	0.00024	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Zoledronate—osteoporosis	2.2e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Risedronate—osteoporosis	2.2e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Pamidronate—osteoporosis	2.2e-05	0.000239	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ibandronate—osteoporosis	2.19e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Risedronate—osteoporosis	2.19e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Estradiol—osteoporosis	2.18e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Zoledronate—osteoporosis	2.18e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Pamidronate—osteoporosis	2.18e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Alendronate—osteoporosis	2.18e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Calcitriol—osteoporosis	2.18e-05	0.000237	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Zoledronate—osteoporosis	2.18e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Estradiol—osteoporosis	2.17e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Zoledronate—osteoporosis	2.17e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Estradiol—osteoporosis	2.17e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Pamidronate—osteoporosis	2.17e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Zoledronate—osteoporosis	2.17e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	2.16e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Estradiol—osteoporosis	2.16e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Pamidronate—osteoporosis	2.16e-05	0.000235	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Zoledronate—osteoporosis	2.16e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Calcitriol—osteoporosis	2.15e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Zoledronate—osteoporosis	2.15e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	2.14e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Raloxifene—osteoporosis	2.14e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Pamidronate—osteoporosis	2.14e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Estropipate—osteoporosis	2.14e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Conjugated Estrogens—osteoporosis	2.14e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	2.14e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Estradiol—osteoporosis	2.13e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Conjugated Estrogens—osteoporosis	2.12e-05	0.000231	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ibandronate—osteoporosis	2.12e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Zoledronate—osteoporosis	2.12e-05	0.00023	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Pamidronate—osteoporosis	2.11e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Estradiol—osteoporosis	2.11e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Alendronate—osteoporosis	2.11e-05	0.000229	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Conjugated Estrogens—osteoporosis	2.1e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Pamidronate—osteoporosis	2.1e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Conjugated Estrogens—osteoporosis	2.1e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Estradiol—osteoporosis	2.1e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Estradiol—osteoporosis	2.1e-05	0.000228	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Pamidronate—osteoporosis	2.09e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Risedronate—osteoporosis	2.09e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Conjugated Estrogens—osteoporosis	2.09e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Ethinyl Estradiol—osteoporosis	2.08e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Pamidronate—osteoporosis	2.08e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Calcitriol—osteoporosis	2.08e-05	0.000226	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Conjugated Estrogens—osteoporosis	2.08e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Zoledronate—osteoporosis	2.07e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Ethinyl Estradiol—osteoporosis	2.07e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Ethinyl Estradiol—osteoporosis	2.07e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Raloxifene—osteoporosis	2.07e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	2.07e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Estradiol—osteoporosis	2.07e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Estradiol—osteoporosis	2.06e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Estropipate—osteoporosis	2.06e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Estradiol—osteoporosis	2.05e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ibandronate—osteoporosis	2.05e-05	0.000223	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Estropipate—osteoporosis	2.04e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Estropipate—osteoporosis	2.04e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Conjugated Estrogens—osteoporosis	2.04e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Estradiol—osteoporosis	2.04e-05	0.000221	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Risedronate—osteoporosis	2.03e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Estradiol—osteoporosis	2.03e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Estropipate—osteoporosis	2.03e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Alendronate—osteoporosis	2.03e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Zoledronate—osteoporosis	2.02e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Risedronate—osteoporosis	2.02e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Risedronate—osteoporosis	2.02e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Estradiol—osteoporosis	2.01e-05	0.000219	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Alendronate—osteoporosis	2.01e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Zoledronate—osteoporosis	2.01e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Alendronate—osteoporosis	2.01e-05	0.000218	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Pamidronate—osteoporosis	2e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Conjugated Estrogens—osteoporosis	2e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Alendronate—osteoporosis	2e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Zoledronate—osteoporosis	1.99e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Raloxifene—osteoporosis	1.99e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Pamidronate—osteoporosis	1.99e-05	0.000216	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Zoledronate—osteoporosis	1.98e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Raloxifene—osteoporosis	1.98e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Raloxifene—osteoporosis	1.97e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Zoledronate—osteoporosis	1.97e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ibandronate—osteoporosis	1.97e-05	0.000214	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Estradiol—osteoporosis	1.96e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Raloxifene—osteoporosis	1.96e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ibandronate—osteoporosis	1.96e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ibandronate—osteoporosis	1.95e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Zoledronate—osteoporosis	1.95e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	1.95e-05	0.000211	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Estradiol—osteoporosis	1.94e-05	0.000211	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ibandronate—osteoporosis	1.94e-05	0.000211	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Conjugated Estrogens—osteoporosis	1.93e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	1.93e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Calcitriol—osteoporosis	1.93e-05	0.00021	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Zoledronate—osteoporosis	1.93e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Estradiol—osteoporosis	1.93e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Estropipate—osteoporosis	1.92e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Pamidronate—osteoporosis	1.92e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Pamidronate—osteoporosis	1.92e-05	0.000209	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Conjugated Estrogens—osteoporosis	1.92e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Zoledronate—osteoporosis	1.92e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Estradiol—osteoporosis	1.91e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Calcitriol—osteoporosis	1.91e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Zoledronate—osteoporosis	1.91e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Calcitriol—osteoporosis	1.91e-05	0.000208	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Conjugated Estrogens—osteoporosis	1.91e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Calcitriol—osteoporosis	1.9e-05	0.000207	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Conjugated Estrogens—osteoporosis	1.9e-05	0.000206	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Zoledronate—osteoporosis	1.9e-05	0.000206	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Alendronate—osteoporosis	1.89e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Estradiol—osteoporosis	1.89e-05	0.000205	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Risedronate—osteoporosis	1.88e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Estradiol—osteoporosis	1.88e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Conjugated Estrogens—osteoporosis	1.88e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Ethinyl Estradiol—osteoporosis	1.88e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Estradiol—osteoporosis	1.88e-05	0.000204	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Raloxifene—osteoporosis	1.86e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Conjugated Estrogens—osteoporosis	1.86e-05	0.000202	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ethinyl Estradiol—osteoporosis	1.85e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Estradiol—osteoporosis	1.85e-05	0.000201	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	1.85e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Conjugated Estrogens—osteoporosis	1.84e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ibandronate—osteoporosis	1.84e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Estradiol—osteoporosis	1.84e-05	0.0002	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Risedronate—osteoporosis	1.83e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Zoledronate—osteoporosis	1.83e-05	0.000199	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Conjugated Estrogens—osteoporosis	1.83e-05	0.000198	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Zoledronate—osteoporosis	1.81e-05	0.000197	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Risedronate—osteoporosis	1.81e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Calcitriol—osteoporosis	1.8e-05	0.000196	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ethinyl Estradiol—osteoporosis	1.79e-05	0.000195	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Pamidronate—osteoporosis	1.79e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Estradiol—osteoporosis	1.78e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Estradiol—osteoporosis	1.78e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Estradiol—osteoporosis	1.78e-05	0.000194	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Estradiol—osteoporosis	1.78e-05	0.000193	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	1.77e-05	0.000192	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Zoledronate—osteoporosis	1.76e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Estradiol—osteoporosis	1.76e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Zoledronate—osteoporosis	1.75e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Zoledronate—osteoporosis	1.75e-05	0.000191	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Risedronate—osteoporosis	1.75e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	1.75e-05	0.00019	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Estradiol—osteoporosis	1.74e-05	0.000189	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Pamidronate—osteoporosis	1.74e-05	0.000189	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ethinyl Estradiol—osteoporosis	1.73e-05	0.000188	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Estradiol—osteoporosis	1.72e-05	0.000187	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Pamidronate—osteoporosis	1.72e-05	0.000187	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Estradiol—osteoporosis	1.71e-05	0.000186	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Estradiol—osteoporosis	1.71e-05	0.000186	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Estradiol—osteoporosis	1.7e-05	0.000185	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Conjugated Estrogens—osteoporosis	1.7e-05	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Risedronate—osteoporosis	1.69e-05	0.000184	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Conjugated Estrogens—osteoporosis	1.69e-05	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Conjugated Estrogens—osteoporosis	1.69e-05	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Estradiol—osteoporosis	1.68e-05	0.000183	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Estradiol—osteoporosis	1.68e-05	0.000182	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Estradiol—osteoporosis	1.67e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ethinyl Estradiol—osteoporosis	1.67e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Pamidronate—osteoporosis	1.66e-05	0.000181	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Estradiol—osteoporosis	1.66e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Estradiol—osteoporosis	1.65e-05	0.00018	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ethinyl Estradiol—osteoporosis	1.65e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ethinyl Estradiol—osteoporosis	1.65e-05	0.000179	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ethinyl Estradiol—osteoporosis	1.64e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Zoledronate—osteoporosis	1.64e-05	0.000178	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Risedronate—osteoporosis	1.63e-05	0.000176	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Risedronate—osteoporosis	1.61e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Risedronate—osteoporosis	1.61e-05	0.000175	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Pamidronate—osteoporosis	1.61e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Risedronate—osteoporosis	1.6e-05	0.000174	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Zoledronate—osteoporosis	1.59e-05	0.000173	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	1.59e-05	0.000623	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.59e-05	0.000621	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—IL6—osteoporosis	1.58e-05	0.000617	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Conjugated Estrogens—osteoporosis	1.57e-05	0.000171	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Zoledronate—osteoporosis	1.57e-05	0.00017	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.56e-05	0.000613	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTH—osteoporosis	1.56e-05	0.000611	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Estradiol—osteoporosis	1.56e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ethinyl Estradiol—osteoporosis	1.56e-05	0.000169	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Estradiol—osteoporosis	1.55e-05	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Pamidronate—osteoporosis	1.54e-05	0.000168	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Estradiol—osteoporosis	1.54e-05	0.000167	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RAP1A—osteoporosis	1.53e-05	0.000601	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Conjugated Estrogens—osteoporosis	1.53e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Pamidronate—osteoporosis	1.53e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Pamidronate—osteoporosis	1.53e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Estradiol—osteoporosis	1.52e-05	0.000166	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.52e-05	0.000597	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Pamidronate—osteoporosis	1.52e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CNR2—osteoporosis	1.52e-05	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SOST—osteoporosis	1.52e-05	0.000596	CbGpPWpGaD
Medroxyprogesterone Acetate—Somnolence—Estradiol—osteoporosis	1.52e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Zoledronate—osteoporosis	1.52e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Risedronate—osteoporosis	1.52e-05	0.000165	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Conjugated Estrogens—osteoporosis	1.51e-05	0.000164	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RPL24—osteoporosis	1.51e-05	0.00059	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Estradiol—osteoporosis	1.51e-05	0.000163	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NFATC1—osteoporosis	1.5e-05	0.000586	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	1.49e-05	0.000585	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.49e-05	0.000583	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Estradiol—osteoporosis	1.49e-05	0.000161	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RPL24—osteoporosis	1.48e-05	0.000582	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—DKK1—osteoporosis	1.48e-05	0.000582	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ENO1—osteoporosis	1.48e-05	0.000581	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PSMA5—osteoporosis	1.48e-05	0.000581	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PSMA2—osteoporosis	1.48e-05	0.000581	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Estradiol—osteoporosis	1.48e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—KL—osteoporosis	1.48e-05	0.000578	CbGpPWpGaD
Medroxyprogesterone Acetate—Fatigue—Estradiol—osteoporosis	1.47e-05	0.00016	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TLN1—osteoporosis	1.47e-05	0.000575	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Zoledronate—osteoporosis	1.47e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Estradiol—osteoporosis	1.46e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Conjugated Estrogens—osteoporosis	1.46e-05	0.000159	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PSMA2—osteoporosis	1.46e-05	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PSMA5—osteoporosis	1.46e-05	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.46e-05	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—TNF—osteoporosis	1.46e-05	0.000571	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.45e-05	0.000568	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Pamidronate—osteoporosis	1.44e-05	0.000157	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—POMC—osteoporosis	1.44e-05	0.000565	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—WNT1—osteoporosis	1.43e-05	0.00056	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.42e-05	0.000558	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Conjugated Estrogens—osteoporosis	1.41e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Zoledronate—osteoporosis	1.41e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Estradiol—osteoporosis	1.41e-05	0.000153	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Zoledronate—osteoporosis	1.4e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Estradiol—osteoporosis	1.4e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Zoledronate—osteoporosis	1.4e-05	0.000152	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGA—osteoporosis	1.39e-05	0.000545	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Zoledronate—osteoporosis	1.39e-05	0.000151	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALCR—osteoporosis	1.38e-05	0.000539	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTH1R—osteoporosis	1.38e-05	0.000539	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TGFB1—osteoporosis	1.37e-05	0.000537	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Conjugated Estrogens—osteoporosis	1.36e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Estradiol—osteoporosis	1.36e-05	0.000148	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Estradiol—osteoporosis	1.35e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Estradiol—osteoporosis	1.35e-05	0.000147	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Conjugated Estrogens—osteoporosis	1.35e-05	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Conjugated Estrogens—osteoporosis	1.35e-05	0.000146	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Conjugated Estrogens—osteoporosis	1.34e-05	0.000145	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.33e-05	0.000521	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.33e-05	0.00052	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ESR2—osteoporosis	1.32e-05	0.000519	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Zoledronate—osteoporosis	1.32e-05	0.000143	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTHLH—osteoporosis	1.29e-05	0.000507	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BMP2—osteoporosis	1.29e-05	0.000507	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—VDR—osteoporosis	1.28e-05	0.000502	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—TNF—osteoporosis	1.28e-05	0.000501	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—ESR1—osteoporosis	1.27e-05	0.000498	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Conjugated Estrogens—osteoporosis	1.27e-05	0.000138	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—P4HB—osteoporosis	1.27e-05	0.000496	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—FGB—osteoporosis	1.27e-05	0.000496	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.26e-05	0.000494	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Estradiol—osteoporosis	1.26e-05	0.000137	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.24e-05	0.000486	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.24e-05	0.000485	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTH—osteoporosis	1.23e-05	0.000482	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Estradiol—osteoporosis	1.23e-05	0.000133	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PSMA5—osteoporosis	1.22e-05	0.000479	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PSMA2—osteoporosis	1.22e-05	0.000479	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.21e-05	0.000475	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Estradiol—osteoporosis	1.21e-05	0.000131	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RAP1A—osteoporosis	1.21e-05	0.000474	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CNR2—osteoporosis	1.2e-05	0.00047	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP19A1—osteoporosis	1.19e-05	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.18e-05	0.000464	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NFATC1—osteoporosis	1.18e-05	0.000462	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—IL6—osteoporosis	1.18e-05	0.000461	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—POMC—osteoporosis	1.17e-05	0.000459	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—DKK1—osteoporosis	1.17e-05	0.000459	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Estradiol—osteoporosis	1.17e-05	0.000127	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.16e-05	0.000454	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—ADCY5—osteoporosis	1.16e-05	0.000453	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CALCA—osteoporosis	1.14e-05	0.000446	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Estradiol—osteoporosis	1.13e-05	0.000123	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—PSMA5—osteoporosis	1.13e-05	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PSMA2—osteoporosis	1.13e-05	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—WNT1—osteoporosis	1.13e-05	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.11e-05	0.000433	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—FDPS—osteoporosis	1.1e-05	0.000433	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PKM—osteoporosis	1.1e-05	0.000433	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGA—osteoporosis	1.1e-05	0.00043	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MGLL—osteoporosis	1.09e-05	0.000428	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Estradiol—osteoporosis	1.09e-05	0.000118	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Estradiol—osteoporosis	1.08e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Estradiol—osteoporosis	1.08e-05	0.000117	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Estradiol—osteoporosis	1.07e-05	0.000116	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LRP5—osteoporosis	1.07e-05	0.000418	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MTHFR—osteoporosis	1.06e-05	0.000417	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—VDR—osteoporosis	1.05e-05	0.000412	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPD2—osteoporosis	1.05e-05	0.00041	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PGLS—osteoporosis	1.05e-05	0.00041	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.05e-05	0.00041	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KL—osteoporosis	1.03e-05	0.000405	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—IL6—osteoporosis	1.03e-05	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.03e-05	0.000404	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.03e-05	0.000402	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.02e-05	0.000401	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BMP2—osteoporosis	1.02e-05	0.0004	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTHLH—osteoporosis	1.02e-05	0.0004	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LRP6—osteoporosis	1.02e-05	0.0004	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Estradiol—osteoporosis	1.02e-05	0.00011	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—IRS2—osteoporosis	1.01e-05	0.000396	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ESR2—osteoporosis	1.01e-05	0.000395	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—FGB—osteoporosis	9.98e-06	0.000391	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.86e-06	0.000386	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ADCY5—osteoporosis	9.69e-06	0.000379	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GPX1—osteoporosis	9.65e-06	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	9.64e-06	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PSMA2—osteoporosis	9.64e-06	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PSMA5—osteoporosis	9.64e-06	0.000378	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ATIC—osteoporosis	9.58e-06	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PNP—osteoporosis	9.58e-06	0.000375	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	9.55e-06	0.000374	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—POMC—osteoporosis	9.53e-06	0.000373	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—IL6—osteoporosis	9.25e-06	0.000362	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—FDPS—osteoporosis	8.99e-06	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PKM—osteoporosis	8.99e-06	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CALCA—osteoporosis	8.98e-06	0.000352	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	8.92e-06	0.00035	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—MTHFR—osteoporosis	8.91e-06	0.000349	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IRS1—osteoporosis	8.83e-06	0.000346	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PSMA5—osteoporosis	8.7e-06	0.000341	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PSMA2—osteoporosis	8.7e-06	0.000341	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—MYC—osteoporosis	8.68e-06	0.00034	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TLN1—osteoporosis	8.61e-06	0.000337	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PSMA5—osteoporosis	8.57e-06	0.000336	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PSMA2—osteoporosis	8.57e-06	0.000336	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPD2—osteoporosis	8.52e-06	0.000334	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PGLS—osteoporosis	8.52e-06	0.000334	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6R—osteoporosis	8.3e-06	0.000325	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KL—osteoporosis	8.16e-06	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CA2—osteoporosis	8.14e-06	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—OXCT1—osteoporosis	8.14e-06	0.000319	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ADCY5—osteoporosis	8.1e-06	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ESR1—osteoporosis	8.03e-06	0.000315	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—VDR—osteoporosis	8.01e-06	0.000314	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MGLL—osteoporosis	7.94e-06	0.000311	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SPP1—osteoporosis	7.84e-06	0.000307	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PNP—osteoporosis	7.8e-06	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ATIC—osteoporosis	7.8e-06	0.000305	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ESR2—osteoporosis	7.77e-06	0.000304	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR2—osteoporosis	7.65e-06	0.0003	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.48e-06	0.000293	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—P4HB—osteoporosis	7.43e-06	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTH—osteoporosis	7.23e-06	0.000283	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—POMC—osteoporosis	7.12e-06	0.000279	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RAP1A—osteoporosis	7.1e-06	0.000278	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IRS2—osteoporosis	7.09e-06	0.000278	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CNR2—osteoporosis	7.04e-06	0.000276	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LEP—osteoporosis	6.93e-06	0.000272	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NFATC1—osteoporosis	6.93e-06	0.000271	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—DKK1—osteoporosis	6.87e-06	0.000269	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—IDH2—osteoporosis	6.75e-06	0.000264	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—OXCT1—osteoporosis	6.63e-06	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CA2—osteoporosis	6.63e-06	0.00026	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ESR1—osteoporosis	6.62e-06	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—WNT1—osteoporosis	6.62e-06	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MYC—osteoporosis	6.61e-06	0.000259	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MGLL—osteoporosis	6.46e-06	0.000253	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGA—osteoporosis	6.44e-06	0.000252	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADCY5—osteoporosis	6.39e-06	0.00025	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP27A1—osteoporosis	6.34e-06	0.000249	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—POMC—osteoporosis	6.29e-06	0.000246	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IRS1—osteoporosis	6.19e-06	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SPP1—osteoporosis	6.18e-06	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ACP5—osteoporosis	6.17e-06	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—VDR—osteoporosis	6.17e-06	0.000242	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ESR1—osteoporosis	6.12e-06	0.00024	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.09e-06	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.09e-06	0.000239	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—VDR—osteoporosis	6.08e-06	0.000238	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTHLH—osteoporosis	5.99e-06	0.000235	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BMP2—osteoporosis	5.99e-06	0.000235	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—POMC—osteoporosis	5.96e-06	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PKM—osteoporosis	5.93e-06	0.000232	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—FDPS—osteoporosis	5.93e-06	0.000232	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—FGB—osteoporosis	5.86e-06	0.00023	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6R—osteoporosis	5.81e-06	0.000228	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TPI1—osteoporosis	5.74e-06	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1—osteoporosis	5.73e-06	0.000224	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PSMA2—osteoporosis	5.66e-06	0.000222	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PSMA5—osteoporosis	5.66e-06	0.000222	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPD2—osteoporosis	5.62e-06	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PGLS—osteoporosis	5.62e-06	0.00022	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IRS2—osteoporosis	5.59e-06	0.000219	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—IDH2—osteoporosis	5.49e-06	0.000215	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LEP—osteoporosis	5.47e-06	0.000214	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—P4HB—osteoporosis	5.39e-06	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GAPDH—osteoporosis	5.3e-06	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALCA—osteoporosis	5.27e-06	0.000206	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ESR1—osteoporosis	5.22e-06	0.000205	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP27A1—osteoporosis	5.16e-06	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RAP1A—osteoporosis	5.16e-06	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ATIC—osteoporosis	5.14e-06	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PNP—osteoporosis	5.14e-06	0.000201	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MYC—osteoporosis	5.09e-06	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ACP5—osteoporosis	5.02e-06	0.000197	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	5.02e-06	0.000196	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.96e-06	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MYC—osteoporosis	4.92e-06	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—osteoporosis	4.91e-06	0.000192	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IRS1—osteoporosis	4.88e-06	0.000191	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KL—osteoporosis	4.79e-06	0.000187	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—POMC—osteoporosis	4.7e-06	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TPI1—osteoporosis	4.67e-06	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR1—osteoporosis	4.64e-06	0.000182	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6R—osteoporosis	4.58e-06	0.00018	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—osteoporosis	4.52e-06	0.000177	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.5e-06	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—P4HB—osteoporosis	4.39e-06	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA2—osteoporosis	4.37e-06	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—OXCT1—osteoporosis	4.37e-06	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GAPDH—osteoporosis	4.31e-06	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MGLL—osteoporosis	4.26e-06	0.000167	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RAP1A—osteoporosis	4.2e-06	0.000164	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—MYC—osteoporosis	4.18e-06	0.000164	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ENO1—osteoporosis	4.17e-06	0.000163	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PSMA2—osteoporosis	4.11e-06	0.000161	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PSMA5—osteoporosis	4.11e-06	0.000161	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADCY5—osteoporosis	3.75e-06	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—osteoporosis	3.7e-06	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.66e-06	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SPP1—osteoporosis	3.63e-06	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—IDH2—osteoporosis	3.62e-06	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MYC—osteoporosis	3.44e-06	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—osteoporosis	3.44e-06	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.41e-06	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ENO1—osteoporosis	3.39e-06	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PSMA2—osteoporosis	3.34e-06	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PSMA5—osteoporosis	3.34e-06	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP19A1—osteoporosis	3.33e-06	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ACP5—osteoporosis	3.31e-06	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IRS2—osteoporosis	3.28e-06	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—osteoporosis	3.21e-06	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—MYC—osteoporosis	3.18e-06	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TPI1—osteoporosis	3.08e-06	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—P4HB—osteoporosis	2.9e-06	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IRS1—osteoporosis	2.86e-06	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GAPDH—osteoporosis	2.84e-06	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RAP1A—osteoporosis	2.77e-06	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—POMC—osteoporosis	2.76e-06	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ADCY5—osteoporosis	2.72e-06	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MYC—osteoporosis	2.72e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GPX1—osteoporosis	2.71e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.71e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—osteoporosis	2.71e-06	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6R—osteoporosis	2.69e-06	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—osteoporosis	2.65e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—osteoporosis	2.59e-06	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—osteoporosis	2.5e-06	9.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MYC—osteoporosis	2.45e-06	9.6e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MYC—osteoporosis	2.41e-06	9.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ENO1—osteoporosis	2.24e-06	8.77e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ADCY5—osteoporosis	2.22e-06	8.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GPX1—osteoporosis	2.21e-06	8.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PSMA5—osteoporosis	2.21e-06	8.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PSMA2—osteoporosis	2.21e-06	8.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—osteoporosis	2.04e-06	8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—osteoporosis	2.04e-06	7.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—POMC—osteoporosis	2e-06	7.85e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.79e-06	7.01e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—POMC—osteoporosis	1.63e-06	6.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MYC—osteoporosis	1.59e-06	6.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—osteoporosis	1.59e-06	6.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ADCY5—osteoporosis	1.46e-06	5.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GPX1—osteoporosis	1.46e-06	5.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—osteoporosis	1.34e-06	5.27e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—osteoporosis	1.2e-06	4.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—POMC—osteoporosis	1.08e-06	4.21e-05	CbGpPWpGaD
